Xinying Sun , Wei Xiao , Mengying Wu , Fuqiang Liu , Jiaxin Li , Lei Liu , Jing Wu , Keke Cheng , Jianan Zhang
{"title":"阴沟肠杆菌的乳酸和2,3-丁二醇联合生产","authors":"Xinying Sun , Wei Xiao , Mengying Wu , Fuqiang Liu , Jiaxin Li , Lei Liu , Jing Wu , Keke Cheng , Jianan Zhang","doi":"10.1016/j.bej.2025.109938","DOIUrl":null,"url":null,"abstract":"<div><div>Microbial fermentation technology has advanced rapidly in the field of green chemical production, showcasing broad application prospects. However, current techniques still face challenges such as low carbon utilization efficiency and excessive accumulation of by-products. Additionally, during the fermentation process, carbon sources are released in the form of CO₂, leading to significant carbon loss. In this study, <em>Enterobacter cloacae</em> CICC 10011 was metabolically engineered to achieve the co-production of 2,3-butanediol (2,3-BDO) and lactic acid, while reducing carbon dioxide emissions and improving carbon utilization. By knocking out key genes (<em>pflB</em> and <em>iclR</em>), the pathways for the formation of by-products such as formate, acetate, and ethanol were attenuated, thereby optimizing carbon flux toward the target products. The results showed that under optimal fermentation conditions (aeration rate of 0.4 vvm, pH 6.5, temperature 35 °C), the double-gene deletion strain ECΔpflBΔiclR achieved lactic acid and 2,3-BDO (mixture of stereoisomers) concentrations of 51.03 g/L and 10.44 g/L, respectively, with a total target product yield of 1.76 mol/mol. Compared to the wild-type strain, the production of by-products succinate, acetate, and ethanol was reduced by 70.04 %, 47.10 %, and 89.76 %, respectively. Additionally, CO₂ emissions were reduced by 68.92 %, and carbon conversion efficiency improved by 116.16 %. This strategy provides a novel approach for carbon emission reduction and the co-production of high-value chemicals in fermentation processes.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"225 ","pages":"Article 109938"},"PeriodicalIF":3.7000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Co-production of lactic acid and 2,3-butanediol by genetically engineered Enterobacter cloacae\",\"authors\":\"Xinying Sun , Wei Xiao , Mengying Wu , Fuqiang Liu , Jiaxin Li , Lei Liu , Jing Wu , Keke Cheng , Jianan Zhang\",\"doi\":\"10.1016/j.bej.2025.109938\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Microbial fermentation technology has advanced rapidly in the field of green chemical production, showcasing broad application prospects. However, current techniques still face challenges such as low carbon utilization efficiency and excessive accumulation of by-products. Additionally, during the fermentation process, carbon sources are released in the form of CO₂, leading to significant carbon loss. In this study, <em>Enterobacter cloacae</em> CICC 10011 was metabolically engineered to achieve the co-production of 2,3-butanediol (2,3-BDO) and lactic acid, while reducing carbon dioxide emissions and improving carbon utilization. By knocking out key genes (<em>pflB</em> and <em>iclR</em>), the pathways for the formation of by-products such as formate, acetate, and ethanol were attenuated, thereby optimizing carbon flux toward the target products. The results showed that under optimal fermentation conditions (aeration rate of 0.4 vvm, pH 6.5, temperature 35 °C), the double-gene deletion strain ECΔpflBΔiclR achieved lactic acid and 2,3-BDO (mixture of stereoisomers) concentrations of 51.03 g/L and 10.44 g/L, respectively, with a total target product yield of 1.76 mol/mol. Compared to the wild-type strain, the production of by-products succinate, acetate, and ethanol was reduced by 70.04 %, 47.10 %, and 89.76 %, respectively. Additionally, CO₂ emissions were reduced by 68.92 %, and carbon conversion efficiency improved by 116.16 %. This strategy provides a novel approach for carbon emission reduction and the co-production of high-value chemicals in fermentation processes.</div></div>\",\"PeriodicalId\":8766,\"journal\":{\"name\":\"Biochemical Engineering Journal\",\"volume\":\"225 \",\"pages\":\"Article 109938\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical Engineering Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1369703X25003122\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X25003122","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Co-production of lactic acid and 2,3-butanediol by genetically engineered Enterobacter cloacae
Microbial fermentation technology has advanced rapidly in the field of green chemical production, showcasing broad application prospects. However, current techniques still face challenges such as low carbon utilization efficiency and excessive accumulation of by-products. Additionally, during the fermentation process, carbon sources are released in the form of CO₂, leading to significant carbon loss. In this study, Enterobacter cloacae CICC 10011 was metabolically engineered to achieve the co-production of 2,3-butanediol (2,3-BDO) and lactic acid, while reducing carbon dioxide emissions and improving carbon utilization. By knocking out key genes (pflB and iclR), the pathways for the formation of by-products such as formate, acetate, and ethanol were attenuated, thereby optimizing carbon flux toward the target products. The results showed that under optimal fermentation conditions (aeration rate of 0.4 vvm, pH 6.5, temperature 35 °C), the double-gene deletion strain ECΔpflBΔiclR achieved lactic acid and 2,3-BDO (mixture of stereoisomers) concentrations of 51.03 g/L and 10.44 g/L, respectively, with a total target product yield of 1.76 mol/mol. Compared to the wild-type strain, the production of by-products succinate, acetate, and ethanol was reduced by 70.04 %, 47.10 %, and 89.76 %, respectively. Additionally, CO₂ emissions were reduced by 68.92 %, and carbon conversion efficiency improved by 116.16 %. This strategy provides a novel approach for carbon emission reduction and the co-production of high-value chemicals in fermentation processes.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.